Published in Ann Hematol on May 01, 1991
A clinical trial of active management of labor. N Engl J Med (1995) 3.34
Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol (1989) 3.05
Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. Gastroenterology (1999) 2.66
A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS (1999) 2.54
That confounded P-value. Epidemiology (1998) 2.26
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. J Antimicrob Chemother (2008) 2.17
Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene. J Clin Invest (1984) 2.07
On the perceptual organization of speech. Psychol Rev (1994) 2.06
Low birthweight at term and the timing of fetal exposure to maternal smoking. Am J Public Health (1994) 2.03
High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS (1995) 1.93
The association of fetal sex with the rate of cesarean section. Am J Obstet Gynecol (1997) 1.76
Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii. Proc Natl Acad Sci U S A (1989) 1.73
Nail changes in patients infected with human immunodeficiency virus. A prospective controlled study. Arch Dermatol (1998) 1.69
Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe. N Engl J Med (1985) 1.67
Glucose transport in a kinaseless Saccharomyces cerevisiae mutant. J Bacteriol (1987) 1.64
Monocular acuity norms for the Teller Acuity Cards between ages one month and four years. Invest Ophthalmol Vis Sci (1995) 1.64
Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein. J Immunol (1991) 1.60
Prevalence and significance of anticardiolipin antibodies in Crohn's disease. Dig Dis Sci (1994) 1.47
Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS (1992) 1.47
The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter. J Virol (1994) 1.46
Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients. Arch Dermatol (1996) 1.46
Sensitivity and long-term prognostic value of cardiac troponin-I increase shortly after percutaneous transluminal coronary angioplasty. Clin Cardiol (1998) 1.43
An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules. Eur J Immunol (1989) 1.43
Epidurals and cesareans: the jury is still out. Birth (1999) 1.41
Maternal epidural use and neonatal sepsis evaluation in afebrile mothers. Pediatrics (2001) 1.39
[Acrosyndromes induced by bleomycin in HIV 1 related Kaposi's disease. 5 cases]. Presse Med (1997) 1.39
The calcineurin-NFAT pathway and muscle fiber-type gene expression. Am J Physiol Cell Physiol (2000) 1.37
Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer (2004) 1.33
Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein. J Virol (1993) 1.33
Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein. Gene (1991) 1.32
Practice effects on commonly used measures of executive function across twelve months. Clin Neuropsychol (1999) 1.32
Interaction of the adenovirus L1 52/55-kilodalton protein with the IVa2 gene product during infection. J Virol (1996) 1.28
Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia. Pediatr Res (1975) 1.28
Risks among inner-city young teens: the prevalence of sexual activity, violence, drugs, and smoking. J Adolesc Health (1993) 1.25
Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases. Blut (1976) 1.25
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia (2000) 1.25
Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children. Br J Haematol (2001) 1.24
In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J Clin Invest (2000) 1.24
Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine (2000) 1.23
High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age. J Clin Oncol (1987) 1.16
Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics (1997) 1.15
Arterial thrombosis and protein S deficiency. Thromb Haemost (1989) 1.13
Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Infect Immun (2000) 1.09
[Synthesis of the anomer sialic acid-methylketoside]. Chem Ber (1966) 1.08
Isotypic restriction of the antibody response to human immunodeficiency virus. AIDS Res Hum Retroviruses (1988) 1.07
Treatment of acquired C1-inhibitor deficiency with danazol. Ann Intern Med (1977) 1.07
Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. Leukemia (2012) 1.07
High prevalence of GB virus C/hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis (2000) 1.06
Assessment of Helicobacter pylori gene expression within mouse and human gastric mucosae by real-time reverse transcriptase PCR. Infect Immun (2001) 1.04
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst (2010) 1.04
An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis. Thromb Haemost (1986) 1.03
Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer (2000) 1.03
Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? J Clin Oncol (1991) 1.02
High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer (1997) 1.02
Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study. Biotherapy (1993) 1.02
Soil characteristics, heavy metal availability and vegetation recovery at a former metallurgical landfill: Implications in risk assessment and site restoration. Environ Pollut (2005) 1.02
Association of epidural analgesia with cesarean delivery in nulliparas. Obstet Gynecol (1996) 1.02
Production of cytokines in patients infected by hepatitis C virus. J Med Virol (1998) 1.01
Mixed-lymphocyte reaction as assay for immunological competence of lymphocytes from patients with hodgkin's disease. Lancet (1972) 0.98
Antibodies to the nef protein and to nef peptides in HIV-1-infected seronegative individuals. AIDS Res Hum Retroviruses (1989) 0.98
Porphyria cutanea tarda associated with human immunodeficiency virus infection. Eur J Dermatol (1999) 0.97
Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register. Bone Marrow Transplant (2005) 0.97
Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology. Cancer (1997) 0.97
Circulating procoagulant microparticles in obesity. Diabetes Metab (2006) 0.97
Assessing the role of case mix in cesarean delivery rates. Obstet Gynecol (1998) 0.96
Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Société Française d'Oncologie Pédiatrique. Blood (1993) 0.96
A STUDY OF THE ENZYMES OF STOOLS IN INTESTINAL INTOXICATION. Can Med Assoc J (1931) 0.96
Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV. Clin Infect Dis (2002) 0.95
[Tsukamurella infections. Review of the literature apropos of a case]. Pathol Biol (Paris) (1997) 0.94
Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response. HIV Med (2006) 0.94
Immunogenicity of the human immunodeficiency virus (HIV) recombinant nef gene product. Mapping of T-cell and B-cell epitopes in immunized chimpanzees. AIDS Res Hum Retroviruses (1990) 0.94
Pheochromocytoma and paraganglioma in children: a report of 24 cases of the French Society of Pediatric Oncology. Pediatr Hematol Oncol (1997) 0.93
Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Eur J Gastroenterol Hepatol (1995) 0.92
The association of inter-pregnancy interval with small for gestational age births. Obstet Gynecol (1989) 0.92
[Influence of protein S deficiency on the arterial thrombosis risk]. Presse Med (1991) 0.92
Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice. Eur J Immunol (1989) 0.92
Expression of integrin receptors on 45 clinical neuroblastoma specimens. Int J Cancer (1991) 0.91
Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeks. J Acquir Immune Defic Syndr (2001) 0.91
Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study. HIV Med (2014) 0.91
A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B. Blood (1986) 0.90
Epidemiological issues in perinatal outcomes research. Paediatr Perinat Epidemiol (1999) 0.90
Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS (1995) 0.89
Time associated with components of clinical services rendered by nurse-midwives. Sample data from phase II of nurse-midwifery care to vulnerable populations in the United States. J Nurse Midwifery (1994) 0.89
OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant. Vaccine (1997) 0.89
Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis. J Clin Oncol (1991) 0.89